The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone ... patients treated with Spravato should receive a dose ...

The maximum daily bupropion SR dosage for depression is 400 mg (200 mg taken twice per day). Bupropion XL: The typical starting dosage of bupropion XL for treating depression is 150 mg once per day.

McIntyre said. “We have not seen that.” Research also suggests that esketamine nasal spray doesn’t affect thinking skills the way high doses of ketamine do. What’s Next Along with ...

At launch, the Flexus Core 200 sat at the top of Klipsch’s soundbar range, though a step-up model has since been announced. It’s off to a solid start, especially from a specification perspective. The ...

By Keith Caulfield Bad Bunny’s Debí Tirar Más Fotos captures a second week at No. 1 on the Billboard 200 albums chart (dated Feb. 1), earning 151,000 equivalent album units in the U.S. in the ...

This article will discuss the recommended hepatitis vaccine schedule for children and adults, including doses, timing, side effects, and who should get the vaccine. The following vaccines are approved ...

Copyright 2025 The Associated Press. All Rights Reserved. In this undated photo provided by the South Carolina Department of Corrections, viewing chairs are placed in ...

The nasal spray Spravato, which is made from the drug ... particularly those who haven't responded to previous doses of traditional antidepressants.

Get Instant Summarized Text (Gist) Nearly 10 million malaria vaccine doses have been delivered in Africa during the first year of routine immunization. The RTS,S vaccine pilot from 2019 to 2023 in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Now, researchers have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects. Despite ...

The study consists of two parts, a dose escalation part, with the first patient enrolled in China recently, and a dose selection optimization part which will be initiated after part 1 is completed.